Are the rumours true that Pascal Soriot could leave AstraZeneca for Teva?
London — AstraZeneca CEO Pascal Soriot, responding to rumours he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work together with employees to see the company succeed. A company spokesperson added that he was intending to attend the European Society for Medical Oncology (Esmo) annual meeting in Madrid in September, assuming that AstraZeneca had clinical data on its new immunotherapy medicine ready to present at the event. Soriot did not comment on whether he had received a job offer from Teva in the internal memo to staff, which was sent out at the start of this week. Rumours were "part of everyday business", he said, and AstraZeneca had a policy of not commenting on speculation. "Together, we are poised to achieve something remarkable and that few thought possible," he wrote. "Nothing can break the momentum you have established, and certainly not rumours." The spokesperson confirmed the content of the memo to staff. A report in...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.